Naver Corp. will unveil an upgraded version of the HyperCLOVA X in July in a bid to keep up with the ChatGPT-fueled global competition.
Launched in 2021, HyperCLOVA X is a hyperscale artificial intelligence platform tailored for the Korean language. It can combine users’ data with its AI predecessor and provide more suitable responses to users.
HyperCLOVA X is more Korean user-oriented than other AI models like the chatbot ChatGPT. It has learned from 6,500 times more Korean data than the US model developed by Open AI.
Naver, South Korea’s top portal operator, said the new AI model will help individuals, companies, and countries use their customized AI systems, and create new services and business opportunities.
Kim Yu-won, CEO of Naver Cloud, vowed that they would create a globally competitive AI ecosystem in South Korea.


Instagram Outage Disrupts Thousands of U.S. Users
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
Asian Markets Slip as AI Spending Fears Shake Tech, Wall Street Futures Rebound
Oil Prices Slip as U.S.–Iran Talks Ease Supply Disruption Fears
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



